These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 29074220)
1. Development of a multiplexed tumor-associated autoantibody-based blood test for the detection of colorectal cancer. Fan CW; Kuo YB; Lin GP; Chen SM; Chang SH; Li BA; Chan EC Clin Chim Acta; 2017 Dec; 475():157-163. PubMed ID: 29074220 [TBL] [Abstract][Full Text] [Related]
4. Development of a novel multiplex beads-based assay for autoantibody detection for colorectal cancer diagnosis. Villar-Vázquez R; Padilla G; Fernández-Aceñero MJ; Suárez A; Fuente E; Pastor C; Calero M; Barderas R; Casal JI Proteomics; 2016 Apr; 16(8):1280-90. PubMed ID: 26915739 [TBL] [Abstract][Full Text] [Related]
5. Prospective evaluation of 64 serum autoantibodies as biomarkers for early detection of colorectal cancer in a true screening setting. Chen H; Werner S; Butt J; Zörnig I; Knebel P; Michel A; Eichmüller SB; Jäger D; Waterboer T; Pawlita M; Brenner H Oncotarget; 2016 Mar; 7(13):16420-32. PubMed ID: 26909861 [TBL] [Abstract][Full Text] [Related]
6. Serological proteome analysis approach-based identification of ENO1 as a tumor-associated antigen and its autoantibody could enhance the sensitivity of CEA and CYFRA 21-1 in the detection of non-small cell lung cancer. Dai L; Qu Y; Li J; Wang X; Wang K; Wang P; Jiang BH; Zhang J Oncotarget; 2017 May; 8(22):36664-36673. PubMed ID: 28456790 [TBL] [Abstract][Full Text] [Related]
7. Blood autoantibodies against tumor-associated antigens as biomarkers in early detection of colorectal cancer. Chen H; Werner S; Tao S; Zörnig I; Brenner H Cancer Lett; 2014 May; 346(2):178-87. PubMed ID: 24462820 [TBL] [Abstract][Full Text] [Related]
8. Detection of autoantibodies against Rabphilin-3A-like protein as a potential biomarker in patient's sera of colorectal cancer. Chen JS; Kuo YB; Chou YP; Chan CC; Fan CW; Chen KT; Huang YS; Chan EC Clin Chim Acta; 2011 Jul; 412(15-16):1417-22. PubMed ID: 21536019 [TBL] [Abstract][Full Text] [Related]
9. The Significance of Combined Measurement of p53 Antibody and other Tumor Markers for Colorectal Cancer after Curative Resection. Kawahara D; Fujita F; Hayashi H; Matsuyama T; Eguchi S Hepatogastroenterology; 2015 May; 62(139):624-8. PubMed ID: 26897942 [TBL] [Abstract][Full Text] [Related]
10. Autoantibodies against tumor-associated antigens in the early detection of lung cancer. Dai L; Tsay JC; Li J; Yie TA; Munger JS; Pass H; Rom WN; Zhang Y; Tan EM; Zhang JY Lung Cancer; 2016 Sep; 99():172-9. PubMed ID: 27565936 [TBL] [Abstract][Full Text] [Related]
11. Clinical Value of Serum p53 Antibody in the Diagnosis and Prognosis of Colorectal Cancer. Kunizaki M; Sawai T; Takeshita H; Tominaga T; Hidaka S; To K; Miyazaki T; Hamamoto R; Nanashima A; Nagayasu T Anticancer Res; 2016 Aug; 36(8):4171-5. PubMed ID: 27466527 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of serum autoantibodies against tumor-associated antigens as biomarkers in lung cancer. Li P; Shi JX; Xing MT; Dai LP; Li JT; Zhang JY Tumour Biol; 2017 Oct; 39(10):1010428317711662. PubMed ID: 29022480 [TBL] [Abstract][Full Text] [Related]
13. Combined analysis of survivin autoantibody and carcinoembryonic antigen biomarkers for improved detection of colorectal cancer. Chen JS; Chen KT; Fan WC; Yu JS; Chang YS; Chan EC Clin Chem Lab Med; 2010 May; 48(5):719-25. PubMed ID: 20178447 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of tumour-associated antigen (TAA) miniarray in immunodiagnosis of colon cancer. Liu W; Wang P; Li Z; Xu W; Dai L; Wang K; Zhang J Scand J Immunol; 2009 Jan; 69(1):57-63. PubMed ID: 19140877 [TBL] [Abstract][Full Text] [Related]
15. Multiple serological biomarkers for colorectal cancer detection. Chan CC; Fan CW; Kuo YB; Chen YH; Chang PY; Chen KT; Hung RP; Chan EC Int J Cancer; 2010 Apr; 126(7):1683-90. PubMed ID: 19795454 [TBL] [Abstract][Full Text] [Related]
16. Prediagnostic Antibodies to Serum p53 and Subsequent Colorectal Cancer. Teras LR; Gapstur SM; Maliniak ML; Jacobs EJ; Gansler T; Michel A; Pawlita M; Waterboer T; Campbell PT Cancer Epidemiol Biomarkers Prev; 2018 Feb; 27(2):219-223. PubMed ID: 29254936 [No Abstract] [Full Text] [Related]
17. A panel of autoantibodies as potential early diagnostic serum biomarkers in patients with cervical cancer. Huangfu M; Xu S; Li S; Sun B; Lee KH; Liu L; Sun S Tumour Biol; 2016 Jul; 37(7):8709-14. PubMed ID: 26738866 [TBL] [Abstract][Full Text] [Related]
18. Using a panel of multiple tumor-associated antigens to enhance the autoantibody detection in the immunodiagnosis of ovarian cancer. Wang P; Qin J; Ye H; Li L; Wang X; Zhang J J Cell Biochem; 2019 Mar; 120(3):3091-3100. PubMed ID: 30484895 [TBL] [Abstract][Full Text] [Related]
19. Immunodiagnostic value of combined detection of autoantibodies to tumor-associated antigens as biomarkers in pancreatic cancer. Li J; Wang LJ; Ying X; Han SX; Bai E; Zhang Y; Zhu Q Scand J Immunol; 2012 Mar; 75(3):342-9. PubMed ID: 22010875 [TBL] [Abstract][Full Text] [Related]
20. Development of autoantibody signatures as biomarkers for early detection of colorectal carcinoma. Chang W; Wu L; Cao F; Liu Y; Ma L; Wang M; Zhao D; Li P; Zhang Q; Tan X; Yu Y; Lou Z; Zhao J; Zhang H; Fu C; Cao G Clin Cancer Res; 2011 Sep; 17(17):5715-24. PubMed ID: 21771877 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]